Hester J. T. van Zeeburg

Hester J. T. van Zeeburg

Auto-generated profile, based on publicly available information

Hester J. T. van Zeeburg

Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2008 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
HZHester J. T. van Zeeburg
Hester J. T. van Zeeburg
PSPeter J. F. Snijders
Peter J. F. Snijders
TWThijs Wu
Thijs Wu
EGEliane Gluckman
Eliane Gluckman
JSJean Soulier
Jean Soulier
RBRuud H. Brakenhoff
Ruud H. Brakenhoff
Fanconi anemia is a recessively inherited disease that is characterized by congenital abnormalities, bone marrow failure, and a predisposition to develop cancer, particularly squamous cell carcinomas (SCCs) in the head and neck and anogenital regions. Previous studies of Fanconi anemia SCCs, mainly from US patients, revealed the presence of high-risk human papillomavirus (HPV) DNA in 21 (84%) of 25 tumors analyzed. We examined a panel of 21 SCCs mainly from European Fanconi anemia patients (n = 19 FA patients; 16 head and neck squamous cell carcinomas [HNSCCs], 2 esophageal SCCs, and 3 anogenital SCCs) for their clinical and molecular characteristics, including patterns of allelic loss, TP53 mutations, and the presence of HPV DNA by GP5+/6+ polymerase chain reaction. HPV DNA was detected in only two (10%) of 21 tumors (both anogenital SCCs) but in none of the 16 HNSCCs. Of the 18 tumors analyzed, 10 contained a TP53 mutation. The patterns of allelic loss were comparable to those generally found in sporadic SCCs. Our data show that HPV does not play a major role in squamous cell carcinogenesis in this cohort of Fanconi anemia patients and that the Fanconi anemia SCCs are genetically similar to sporadic SCCs despite having a different etiology.

15 February 2005 in Cancer Research
Verified
Journal Article
Closed access
PDF file
HZHester J.T. van Zeeburg
Hester J.T. van Zeeburg
PSPeter J.F. Snijders
Peter J.F. Snijders
GPGerard Pals
Gerard Pals
MHMario A.J.A. Hermsen
Mario A.J.A. Hermsen
MRMartin A. Rooimans
Martin A. Rooimans
RBRuud H. Brakenhoff
Ruud H. Brakenhoff
Patients with Fanconi anemia (FA) are prone to develop malignancies at an early age. Besides hematologic malignancies, squamous cell carcinomas in the anogenital region and head and neck are also frequently found in these patients. The aim of this study was to generate a panel of head and neck squamous cell carcinoma (HNSCC) cell lines and xenografts of FA HNSCC, and to characterize these cell lines in comparison with a panel of seven cell lines from patients with sporadic HNSCC. Analyses have been done on sensitivity to DNA cross-linking agents, loss of heterozygosity profile, TP53 mutations, TP53 polymorphisms and the presence of human papillomavirus. Four FA HNSCC cell lines were established. Sensitivity to DNA cross-linking agents (cisplatin) in the FA HNSCC cell lines was on average 10 times higher as compared with the sporadic HNSCC cell lines. Human papillomavirus was not detected in any of the FA or sporadic cell lines. No differences were found in loss of heterozygosity pattern, TP53 mutation frequency and TP53 polymorphism between FA and sporadic HNSCC cell lines. This is the first report on the generation of squamous cell lines of FA patients. The FA HNSCC cell lines we have generated may be utilized for future studies and might aid in the development of new preventive therapies for FA patients. The genetic characteristics of these cell lines suggest that FA HNSCC are not very different from sporadic HNSCC, except for the sensitivity to cisplatin which is consistent with the known cellular FA phenotype.

1 November 2004 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
MKMarcin P. Klejman
Marcin P. Klejman
LPLloyd A. Pereira
Lloyd A. Pereira
HZHester J. T. van Zeeburg
Hester J. T. van Zeeburg
SGSiv Gilfillan
Siv Gilfillan
MMMichael Meisterernst
Michael Meisterernst
HTH. T. Marc Timmers
H. T. Marc Timmers
Transcriptional activity of the TATA-binding protein (TBP) is controlled by a variety of proteins. The BTAF1 protein (formerly known as TAFII170/TAF-172 and the human ortholog of Saccharomyces cerevisiae Mot1p) and the NC2 complex composed of NC2α (DRAP1) and NC2β (Dr1) are able to bind to TBP directly and regulate RNA polymerase II transcription both positively and negatively. Here, we present evidence that the NC2α subunit interacts with BTAF1. In contrast, the NC2β subunit is not able to associate with BTAF1 and seems to interfere with the BTAF1-TBP interaction. Addition of NC2α or the NC2 complex can stimulate the ability of BTAF1 to interact with TBP. This function is dependent on the presence of ATP in cell extracts but does not involve the ATPase activity of BTAF1 nor phosphorylation of NC2α. Together, our results constitute the first evidence of the physical cooperation between BTAF1 and NC2α in TBP regulation and provide a framework to understand transcription functions of NC2α and NC2β in vivo.

19 June 2012 in Head & Neck
Verified
Journal Article
Closed access
PDF file
HZHester J.T. van Zeeburg
Hester J.T. van Zeeburg
AGA. Peggy Graveland
A. Peggy Graveland
ABArjen Brink
Arjen Brink
MNMelanie Nguyen
Melanie Nguyen
CLChristiaan René Leemans
Christiaan René Leemans
RBRuud H. Brakenhoff
Ruud H. Brakenhoff

15 June 2004 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
HZHester J. T. van Zeeburg
Hester J. T. van Zeeburg
PSPeter J. F. Snijders
Peter J. F. Snijders
HJHans Joenje
Hans Joenje
RBRuud H. Brakenhoff
Ruud H. Brakenhoff
Kutler et al. ( 1 ) recently reported that human papillomavirus (HPV) DNA is frequently detected in squamous cell carcinomas (SCCs) of Fanconi anemia patients, who are predisposed to develop cancer at an early age, particularly acute myeloid leukemia and SCCs of the head and neck (HNSCCs) and the anogenital region. Kutler et al. speculated that HPV infection might be critically involved in the pathogenesis of SCC in Fanconi anemia patients, which raises hope that vaccination against HPV might prevent such tumors. HPV is known to be etiologically involved in SCCs that arise in the anogenital region (cervix) and in a minority of HNSCCs, particularly those in the oropharynx ( 2 , 3 ) . Inhibitory oncoproteins expressed by HPV cause inactivation of the p53 and pRb pathways. HNSCCs that contain transcriptionally active HPV DNA typically lack mutations in TP53, the gene encoding p53, whereas 50%–60% of HNSCCs that do not contain HPV DNA have mutations in TP53 ( 2 ) .

29 March 2010 in The Journal of Gene Medicine
Verified
Journal Article
Closed access
PDF file
HZHester J. T. van Zeeburg
Hester J. T. van Zeeburg
VBVictor W. van Beusechem
Victor W. van Beusechem
AHAafke Huizenga
Aafke Huizenga
Hidde HaismaHidde Haisma
Hidde Haisma
NKNick Korokhov
Nick Korokhov
RBRuud H. Brakenhoff
Ruud H. Brakenhoff